Hsin-An Hou

26PUBLICATIONS
82CO-AUTHORS
Regenerative medicine (incl. stem cells)Haematological tumoursPredictive and prognostic markersMedical mycologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jun 02, 2026
Selinexor Plus Ruxolitinib in Janus Kinase Inhibitor-Naïve Myelofibrosis: Phase III SENTRY Trial.

|Mar 13, 2026
Prognostic implications of genetic and transcriptomic abnormalities in MDS according to IPSS-R, IPSS-M, and the International Consensus Classification.

Wan-Hsuan Lee, Hsin-An Hou, Chien-Chin Lin

|Jan 06, 2026
Prognostic impact of co-occurring FLT3 mutations across molecular subgroups in intensively treated acute myeloid leukemia: insights from real-world genomic data.

Yu-Sung Chang, Feng-Ming Tien, Yu-Wen Wang

|Jul 31, 2025
A clinico-genomic prognostic model for primary myelodysplastic neoplasm in Asia.

Harinder Gill, Rita Yim, Paul Lee

|Jul 17, 2025
Clinical Practice Recommendations for Myelofibrosis Management in the Asia-Pacific Region: The APAC-MF Alliance.

Keita Kirito, Chul Won Choi, Than Hein

|Jul 10, 2025
Ropeginterferon alfa-2b as a promising alternative to conventional interferon in CDA type 1: a case report of two siblings.

Tyng-Wei Yang, Xavier Cheng-Hong Tsai, Yu-Hsuan Fu

Pageof 5

Frequent Collaborators

14 joint publications

Hwei-Fang Tien

13 joint publications

Wen-Chien Chou

10 joint publications

Feng-Ming Tien

9 joint publications

Yuan-Yeh Kuo